RFHIC Press Release - July 27, 2009
RFHIC Introduces High Efficiency Medical Treatment Amplifiers for Hyperthermia Treatment or RF Ablation
Up to 55% efficiency on AB class amplification
Korea (July 27, 2009) – RFHIC Corporation, manufacturer of active RF & MW components and hybrids for
wireless telecommunication markets, released Hyperthermia treatment or RF ablation purpose RF amplifier. This
pallet amplifier uses GaN-on-SiC technology which is very robust against back power or other damages, and reduces
the need for maintenance.
stages of a cancer treatment often use this effective RF technology to treat patients. This highly efficient power
amplifier use 2.3~2.5GHz frequency, and has a 200W output power, and three stage amplifier design totaling 31dB
gain. Final stage amplifier has 55% efficiency when operated at AB class amplification. When using the power
amplifier on an E-class amplification, the efficiency reaches 90% efficiency.
Above photo shows the 250mm
x 120mm x 30mm size of the amplifier with isolator and low pass filter (LPF). Higher power can be achieved by
combining multiple pallet amplifiers. Fan inclusive designs are available as well.
“Much has been said on
cancer treatment by RF technology, and many research results show hard evidence that this actually works and is
better than traditional medical surgery. Recent post from Samsung Medical Center(SMC) comments that Radiofrequency
ablation, or RFA, treatment has proved to be the most effective and the safest approach to destroying inoperable
early-stage tumors in the liver. RFHIC is proud to support such an industry with high performance RF amplifiers”
said Mr. Kevin Kim, Senior International Sales Manager, RFHIC Corporation.
Samsung Medical Center(SMC) announced that the RFA treatment team has demonstrated a remarkable success rate
across 3,600 cases of liver cancer patients for the ten years from April 1999 to April 2009. The team performed
RFA treatment 3,594 times on 2,600 patients over a 10-year period.
RFMA245 is available in sample quantity immediately. Other higher output, or custom medical amplifier designs
are available from RFHIC as well. For additional information regarding RFHIC’s products, visit www.rfhic.com or
contact firstname.lastname@example.org, (Tel:82-31-250-5011)
RFHIC is a
manufacturer of active RF components and modules primarily for the wired and wireless telecommunication and
broadcasting markets. As a No.1 active component manufacturer in Korea and expanding customer support across the
world, RFHIC is already serving component communication equipments in over 45 international countries, and over
1000 customers. RFHIC was founded in 1999, and has been pioneering in the telecommunication and CATV component
markets with new technology or new product features ever since. Major areas of business include Base Stations,
Repeaters, Cable Networks, LTE, WiMAX, UMTS, Digital TV, Radar, Medical, Military, and Test Equipments for
infrastructure markets. RFHIC is head quartered in Suwon, South Korea, and its US R&D office is located in Cary,
For more information, contact;
Senior International Sales Manager
R&D Director- US Office